Nanoparticles: pharmacological and toxicological significance. 2007

C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.

Nanoparticles are tiny materials (<1000 nm in size) that have specific physicochemical properties different to bulk materials of the same composition and such properties make them very attractive for commercial and medical development. However, nanoparticles can act on living cells at the nanolevel resulting not only in biologically desirable, but also in undesirable effects. In contrast to many efforts aimed at exploiting desirable properties of nanoparticles for medicine, there are limited attempts to evaluate potentially undesirable effects of these particles when administered intentionally for medical purposes. Therefore, there is a pressing need for careful consideration of benefits and side effects of the use of nanoparticles in medicine. This review article aims at providing a balanced update of these exciting pharmacological and potentially toxicological developments. The classes of nanoparticles, the current status of nanoparticle use in pharmacology and therapeutics, the demonstrated and potential toxicity of nanoparticles will be discussed.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050997 Nanomedicine The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments
D036103 Nanotechnology The development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller. Nanotechnologies

Related Publications

C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
August 2001, Neurotoxicity research,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
January 1988, Xenobiotica; the fate of foreign compounds in biological systems,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
July 1977, NIDA research monograph,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
April 1954, Arzneimittel-Forschung,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
September 1970, La Radiologia medica,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
January 2010, Journal of pharmacological and toxicological methods,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
April 1988, Tijdschrift voor diergeneeskunde,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
June 1972, The Southeast Asian journal of tropical medicine and public health,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
January 1984, Pharmacology, biochemistry, and behavior,
C Medina, and M J Santos-Martinez, and A Radomski, and O I Corrigan, and M W Radomski
January 1966, Acta psychiatrica Scandinavica. Supplementum,
Copied contents to your clipboard!